StockData
AstraZeneca PLC logo

AstraZeneca PLC (AZN) stock

AZNNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Score 12/30
$163.95−1.46 (-0.88%)

Close on Oct 19, 2026Market cap $255.76BP/E 25.1Yield 1.91%

AstraZeneca EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

AstraZeneca's EV/EBITDA was 39.1× on Oct 19, 2026, against 53.9× a year earlier. Over the last 5 years it ranged from 34.3× to 390.0×, with a median of 62.1×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 202639.1×−20.8
2025Dec 31, 202559.9×+6.8
2024Dec 31, 202453.1×−65.0
2023Dec 29, 2023118.0×−271.0
2022Dec 30, 2022389.0×+353.4
2017Jan 31, 201735.6×−0.1
2016Dec 30, 201635.7×–

More AstraZeneca figures

See a number that looks wrong?